Vaccine Induced Demyelination

[Guest guest]

Vaccine Induced Demyelination

An explanation for what happens leading to ADD/ADHD or Autism or

other neurological conditions

" This study strengthens the argument that adjuvants may be crucial to

initiating an auto-immune response leading to post-vaccine neurological

symptoms. "

http://www.healing-arts.org/children/vaccines/vaccines-demyelination.htm

Vaccine Induced Demyelination

Myelination is an essential part of human brain development. Nerves

can only conduct pulses of energy efficiently if covered by myelin.

Like insulation on an electric wire, the fatty coating of myelin

keeps the pulses confined and maintains the integrity of the

electrical signal so that it has a high signal-to-noise ratio. When

the insulation on a wire is damaged or destroyed, the flow of

electrical current may be interrupted and a short-circuit occurs.

Oligodendrocyte cells give white matter its color by manufacturing

myelin. If myelin falls into disrepair, nerve axons cease to

function, even though they themselves aren't damaged. Protecting

oligodendrocytes after brain or spinal cord injury might keep nerve

cells intact.

At birth, relatively few pathways have myelin insulation. Myelination

in the human brain continues from before birth until at least 20

years of age. Up until the age of 10 or so, vast areas of the cortex

are not yet myelinated. Up to the age of 20, large areas of the

frontal lobes are not yet myelinated.1

Myelination begins in the developmentally oldest parts of the brain,

like the brain stem, moving to the areas of the nervous system that

have developed more recently, like the prefrontal lobe and cortex.

Myelin spreads throughout the nervous system in stages, which vary

slightly in each individual. Impairment of myelination can alter

neural communication without necessarily causing severe CNS (central

nervous system) damage.

The prefrontal portions of the cerebrum have a profound influence on

human behavior.2 If an individual is injected with vaccines,most of

which have adjuvants like mercury and aluminum compounds, as well as

foreign proteins (some from other species in which the vaccines were

grown) and biological organisms, unprotected nerves may be impacted.

The argument for a role of vaccines in the development of autistic

disorders hinges on these biological effects upon nerves, damaging

them in a way that influences behavior and learning patterns.

The argument for adjuvants evoking an auto-immune response does not

hinge on any inherent neuro-toxicity of these compounds, but on the

initiation of an allergic response.

The model by which adjuvants initiate an immune response is that of

Experimental Allergic Encephalomyelitis (EAE). To date, EAE is

recognized as the best available animal model of several degenerative

human diseases, like multiple sclerosis and post-vaccinal

encephalopathies. EAE3 is generally thought to be an autoimmune

response to myelin basic protein (MBP). Oddly, MBP can also suppress

EAE, and many observations suggest that an independent immune

response to so-called " adjuvant " material is also necessary to EAE

induction. Of course, this is why adjuvants are used in vaccines, to

dramatically increase the likelihood of an immune response to the

administered biological material.

Thus, EAE may be a result of a pair of interactive immune responses,

one against MBP, and one against the adjuvant. If so, the adjuvant

should, like MBP, suppress EAE. Root-Bernstein, et al. (1986)

presented data from experiments on strain 13 guinea pigs

demonstrating EAE suppression by muramyl dipeptide, an active

component of complete Freund's adjuvant. In the past, adjuvants have

only been classified as immunopotentiators, not immunosuppressants.

Apparently, adjuvants are both. This study strengthens the argument

that adjuvants may be crucial to initiating an auto-immune response

leading to post-vaccine neurological symptoms.

----

References

KM, Meade BD, Decker MD, et al. Comparison of 13 acellular

pertussis vaccines: overview and serologic responses. Pediatrics

1995;96:548-57.

Orenstein WA, Brugliera PD. Preface: Immunization in medical

education. Am J Prev Med 1994; 10(suppl):v-viii.

Root-Bernstein RS; Yurochko F; Westall FC. Clinical suppression of

experimental allergic encephalomyelitis by muramyl dipeptide

" adjuvant " . Brain Res Bull, 17: 4, 1986 Oct, 473-6.

----------------------------------------------------------------------------

Written and overseen by Mehl-Madrona, M.D., Ph.D.

Program Director, Continuum Center for Health and Healing, Beth

Israel Hospital / Albert Einstein School of Medicine

--------------------------------------------------------

Sheri Nakken, former R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales UK

Vaccines - http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers & Homeopathy Online/email courses